Alisna, Melanie D.
HRN: 22-58-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/11/2023
02/12/2023
IV
500 Mg
Every 8 Hours For 3 More Doses
S/P 1°LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes